Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > “Heroes of Chemistry” for saving teeth, clean water, new high blood pressure drug

Abstract:
You've never met Sumita B. Mitra, Ph.D. But your teeth probably have encountered the results of this scientist's research. Her genius has helped restore millions of decayed, broken, or discolored teeth to their original bright white, natural beauty.

“Heroes of Chemistry” for saving teeth, clean water, new high blood pressure drug

Washington, DC | Posted on August 16th, 2009

Raise a glass — make that water, please — to toast and honor William E. Mickols, Ph.D., and the late John Cadotte. Millions of people might well do exactly that. Mickols and Cadotte invented the filters used around the world to remove salt from ocean water. In desalinating seawater, the filters transform the world's oceans into a drought-proof source of fresh water for drinking, irrigating crops, raising livestock and sustaining industry.

Ever clap you hands and cheer a favorite baseball or football team? Why not applaud the scientific team that in 2007 put on pharmacy shelves in the United States the first new type of medicine in more than a decade for high blood pressure? High blood pressure is a key factor in heart attacks and strokes that affect one billion people worldwide. And nearly 700 million people are not getting effective treatment.

Getting the idea?

The American Chemical Society (ACS), the world's largest scientific society, puts unsung heroes like these in the limelight once a year, and is announcing the newest inductees into its Heroes of Chemistry "hall of scientific fame" that recognizes the achievements of chemists in industry.

Mitra, Mickols and Cadotte, and a team of 12 scientists from the Novartis Institutes for Biomedical Research, based in Cambridge, Mass., are ACS' 2009 heroes. Mitra is with 3M ESPE Dental Products Division in St. Paul, Minn. Mickols is with the Dow Water & Process Solutions, a subsidiary of The Dow Chemical Company in Midland, Mich.

"Heroes of Chemistry is a wonderful opportunity to recognize the people behind the products, medicines, and technology that are the foundations of modern society," said ACS President Thomas H. Lane, Ph.D. "It puts a human face on chemistry. These products don't just magically appear. Men and women like our 2009 Heroes invent them, develop them, and bring them to market."

The 2009 Heroes of Chemistry will be honored here during ACS' 238th National Meeting. The recognition ceremony and dinner is scheduled for Sunday, Aug. 16, at the Park Hyatt Washington DC hotel. John LaMattina, Ph.D., former Senior Vice President of Pfizer Inc. and former President of Pfizer Global Research and Development, will be keynote speaker. He is the author of Drug Truths: Dispelling the Myths about Pharma R&D.

Mitra invented a whole genre of new materials — including "white fillings" — that dentists around the world use as adhesives to glue crowns and veneers to teeth and to repair decayed, cracked or broken teeth. These materials are thick, semi-solid dental composite "resins" that harden quickly when the dentist exposes them to a curing light. They match the color of a patient's natural teeth, maintaining those bright, toothy smiles.

Experts regard Mitra's "resin-modified glass ionomner technology" as a landmark in modern dental materials. Placed inside when a cavity is ready for filling, for instance, it prevents hot-cold sensitivity and secondary decay. Repairing that decay — which occurs under fillings — costs patients and insurers almost $5 billion annually in the United States alone.

Mitra also invented the first universal or multipurpose dental nanocomposite filling material that can be used for all kinds of tooth repair. Based on nanotechnology, and marketed as 3M ESPE™ Filtek™ Supreme Universal Restorative, it hardens into a material with all the strength and glossy, translucent appearance of natural tooth enamel. It is the No. 1 selling dental composite in the United States.

"Dr. Mitra's extraordinary inventions have changed the field of dentistry for dentists and patients around the world," said Fred J. Palensky, Ph.D., executive vice president, Research and Development and chief technology officer at 3M. "Her discoveries will influence and benefit society for decades. The financial impact of her work is enormous and far-reaching. To date, her research has resulted in commercialized products that have contributed nearly $2 billion to 3M's revenue."

ACS is honoring Cadotte and Mickols for developing the modern membranes used in the world's largest desalination method — termed reverse osmosis (RO) — for removing salt from seawater and brackish water so that it is fit for human consumption. In reverse osmosis, pumps force salt water through a membrane. Salt and other unwanted materials in the water can't pass through the membrane and stays behind in one tank, while fresh water collects on the other side of the membrane.

In the 1970s, Cadotte invented the FT-30 polymer and process for making it into a membrane. This is the polymer and process used by almost all of the world's current producers of RO membranes. Mickols later improved on that work. He invented high-efficiency FilmTecTM RO membranes that can treat up to five times more water per hour, with two to four times greater energy-efficiency and lower cost. Sales of these membranes from Dow Water & Process Solutions generated $320 million in revenues last year.

"Nine billion gallons of drinking water and industrial process water are being produced every day around the world with Dow technology," said William Banholzer, Ph.D., executive vice president and chief technology officer at Dow. "This technology has had great benefits to humanity. Supplies of clean fresh water are under enormous stress because of global population growth, environmental degradation, and climate change that is altering patterns of water availability in complex ways."

ACS is recognizing the Novartis team for discovering aliskiren (marketed as Tekturna® and Rasilez®), a new medication for high blood pressure. Members of the team include Nissim Claude Cohen, Richard Göschke, Peter Herold, Robert Mah, Jürgen Maibaum, Joseph Rahuel, Vittorio Rasetti, Pascal Rigollier, Heinrich Rueeger, Walter Schilling, Stefan Stutz, and Yasuchika Yamaguchi.

Tekturna® treats high blood pressure in a way fundamentally different from the dozens of medications for that condition. It works by interfering with the action of an enzyme called renin, which is produced in the kidneys. Renin triggers a process that can contribute to high blood pressure. As scientific understanding of renin grew in the early 1980s, pharmaceutical companies around the world began searching for renin inhibitors. The Novartis team developed the first such drug approved for use in the United States, and so far the only direct renin inhibitor available to patients.

"The Novartis team made remarkable progress in developing this new drug," said Scott A. Biller, Ph.D., vice president and head of global discovery chemistry. "It provides powerful blood pressure lowering efficacy that lasts for 24 hours and beyond with excellent tolerability, which is comparable to placebo. Tekturna® and Rasilez®, has demonstrated organ protection potential beyond current treatments, by reducing key markers of kidney disease and heart failure."

Launched in 1996, the Heroes of Chemistry program honors chemical innovators in industry "whose work has led to the welfare and progress of humanity" in a significant way in the past decade. Candidates are nominated by their companies and an ACS panel reviews the nominations with an eye toward recognizing research that has lead to the successful development and commercial sale of a technological product.

####

About American Chemical Society
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 154,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

For more information, please click here

Contacts:
Media Inquiries:
Michael Bernstein

202-249-4014 (Meeting, Aug. 15-19)
202-872-6042 (Before Aug. 15)

Michael Woods

202-249-4014 (Meeting, Aug. 15-19)
202-872-6293 (Before Aug. 15)

Copyright © American Chemical Society

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Products

QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014

Nanovations Sets new Benchmark in Automotive Windscreen Coating Durability: Nanovations new automotive glass coating Vision Protect, sets new benchmark in glass coating durability March 23rd, 2014

Tawada CleanTech to show fabric duct and eco cool coating in MegaBuild March 21st, 2014

NEI Introduces Self-healing Anti-corrosion Coating for Zinc-Plated and Galvanized Steel March 14th, 2014

Profiles

Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011

Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011

Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010

Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010

Announcements

Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014

NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Personal Care

Good vibrations: Using light-heated water to deliver drugs - Researchers use near-infrared light to warm water-infused polymeric particles April 1st, 2014

Iranian Food Industry Utilizes Lipid Nanocarriers for Beta-Carotene Enrichment January 23rd, 2014

ASTM International Nanotechnology Committee Approves Airborne Nanoparticle Measurement Standard December 10th, 2013

Antibacterial Nanocomposites Produced from Offset Lithography Inks December 1st, 2013

Dental

Newly-Produced Bone Cement Able to Carry Medicine April 21st, 2014

Plasma tool for destroying cancer cells: Inducing biological tissue damage with an atmospheric pressure plasma source could open the door to many applications in medicine March 26th, 2014

Scientists develop world’s first light-activated antimicrobial surface that also works in the dark March 24th, 2014

Inhibition of oral biofilm and cell-cell communication using natural-products derivatives March 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE